Insider filing · XENE
Steven Gannon
Director
profile →
Xenon Pharmaceuticals Inc.
XENE · Healthcare · 12 filings in 24 months
ticker →
Steven Gannon sold $641K of Xenon Pharmaceuticals (XENE)
Executed Aug 11, disclosed Aug 13, 2 days later.
Value, as filed
$641K
10,000 sh × $64.06
Executed
Aug 11
the trade date, as filed
Disclosed
Aug 13
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
SGSteven Gannon (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Xenon Pharmaceuticals Inc. (XENE). The largest single filing was $641K of XENE (10,000 sh × $64.06, as filed), executed Aug 11.
The name
XENEHealthcare · Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therap…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→